Sancilio Pharmaceuticals Company, Inc. Bankruptcy Docket

Cases

Plan effective May 31, 2019

Updated Oct 3, 7:58 PM ET

Petition filed
Jun 5, 2018
Plan confirmed
Apr 9, 2019

Sancilio Pharmaceuticals reached an effective Chapter 11 liquidation plan, as reported in the June 3, 2019 effective-date notice Dkt. 399. The June 30, 2021 final decree Dkt. 443 closed the affiliate cases but left Sancilio Pharmaceuticals’ case open, with administration of the liquidation plan remaining its path.

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

MCA Financial Group, Ltd.Financial Advisor
Emerald Capital AdvisorsFinancial Advisor
Cassel Salpeter & Co., LLCInvestment Banker

Recent activity

Sancilio Pharmaceuticals creditors’ committee appointed
Jul 3, 2018
· p. 1 Dkt. 112

Recent filings

Oct 4Notice of Change of Address Notice of Change of Firm Address Filed by Oracle America, Inc.. (Christianson, Shawn)Bankr. D. Del., No. 18-11333, ECF No. 470Dkt. 470
Jul 22Notice of Satisfaction of Claim Third Notice of Satisfaction of Claims. Filed by Faegre Drinker Biddle & Reath LLP. (Attachments: # (1) Exhibit A) (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 469Dkt. 469
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 12/31/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 468Dkt. 468
Feb 25Chapter 11 Post-Confirmation Report for Case Number 18-11334 for the Quarter Ending: 06/30/2021 Sancilio & Company, Inc. Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 465Dkt. 465
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 09/30/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 467Dkt. 467
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 464Dkt. 464

Full docket (484) →

Case facts and filing dates come from court records.

Plan effective May 31, 2019

Updated Oct 3, 7:58 PM ET

Petition filed
Jun 5, 2018
Plan confirmed
Apr 9, 2019

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

MCA Financial Group, Ltd.Financial Advisor
Emerald Capital AdvisorsFinancial Advisor
Cassel Salpeter & Co., LLCInvestment Banker

Recent activity

Sancilio Pharmaceuticals creditors’ committee appointed
Jul 3, 2018
· p. 1 Dkt. 112

Recent filings

Oct 4Notice of Change of Address Notice of Change of Firm Address Filed by Oracle America, Inc.. (Christianson, Shawn)Bankr. D. Del., No. 18-11333, ECF No. 470Dkt. 470
Jul 22Notice of Satisfaction of Claim Third Notice of Satisfaction of Claims. Filed by Faegre Drinker Biddle & Reath LLP. (Attachments: # (1) Exhibit A) (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 469Dkt. 469
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 12/31/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 468Dkt. 468
Feb 25Chapter 11 Post-Confirmation Report for Case Number 18-11334 for the Quarter Ending: 06/30/2021 Sancilio & Company, Inc. Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 465Dkt. 465
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 09/30/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 467Dkt. 467
Feb 25Chapter 11 Post-Confirmation Report for the Quarter Ending: 06/30/2021 Sancilio Pharmaceuticals Company, Inc. [18-11333] Filed by Faegre Drinker Biddle & Reath LLP. (Marasco, Jaclyn)Bankr. D. Del., No. 18-11333, ECF No. 464Dkt. 464

Full docket (484) →

Case facts and filing dates come from court records.

Sancilio Pharmaceuticals Company, Inc.

Plan effective May 31, 2019

Research this case

Key firms

Recent activity

Sancilio Pharmaceuticals creditors’ committee appointed

Recent filings

Plan effective May 31, 2019

Research this case

Key firms

Recent activity

Sancilio Pharmaceuticals creditors’ committee appointed

Recent filings

Sancilio Pharmaceuticals Company, Inc.

Plan effective May 31, 2019

Research this case

Key firms

Recent activity

Sancilio Pharmaceuticals creditors’ committee appointed

Recent filings